Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species

Marine Drugs

Volumn 7, Issue 2, 2009, Pages 196-209

  Marshall, Kathryn M ^a,b   Andjelic, Cynthia D ^a   Tasdemir, Deniz ^a,c   Concepción, Gisela P ^d   Ireland, Chris M ^a   Barrows, Louis R ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d University of the Philippines Diliman   (Philippines)

Author keywords

Amphimedine; Deoxyamphimedine; Neoamphimedine; Pyridoacridine; Reactive oxygen species

Indexed keywords

ACRIDINE DERIVATIVE; ALKALOID DERIVATIVE; AMPHIMEDINE; DEOXYAMPHIMEDINE; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; NEOAMPHIMEDINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN;

EID: 66449103251     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md7020196     Document Type: Article

References (41)

1. Brahic, C.; Darro, F.; Belloir, M.; Bastide, J.; Kiss, R.; Delfourne, E. Synthesis and cytotoxic evaluation of analogues of the marine pyridoacridine amphimedine. Bioorg. Med. Chem. 2002, 10, 2845-2853.
2. Delfourne, E.; Darro, F.; Bontemps-Subielos, N.; Decaestecker, C.; Bastide, J.; Frydman, A.; Kiss, R. Synthesis and characterization of the antitumor activities of analogues of meridine, a marine pyridoacridine alkaloid. J. Med. Chem. 2001, 44, 3275-3282.
3. Delfourne, E.; Darro, F.; Portefaix, P.; Galaup, C.; Bayssade, S.; Bouteille, A.; Le Corre, L.; Bastide, J.; Collignon, F.; Lesur, B.; Frydman, A.; Kiss, R. Synthesis and in vitro antitumor activity of novel ring D analogues of the marine pyridoacridine ascididemin: structure-activity relationship. J. Med. Chem. 2002, 45, 3765-3771.
4. Delfourne, E.; Kiss, R.; Le Corre, L.; Dujols, F.; Bastide, J.; Collignon, F.; Lesur, B.; Frydman, A.; Darro, F. Synthesis and in vitro antitumor activity of phenanthrolin-7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine: structure-activity relationship. J. Med. Chem. 2003, 46, 3536-3545.
5. Delfourne, E.; Kiss, R.; Le Corre, L.; Dujols, F.; Bastide, J.; Collignon, F.; Lesur, B.; Frydman, A.; Darro, F. Synthesis and in vitro antitumor activity of ring C and D-substituted phenanthrolin- 7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine. Bioorg. Med. Chem. 2004, 12, 3987-3994.
6. Delfourne, E.; Kiss, R.; Le Corre, L.; Merza, J.; Bastide, J.; Frydman, A.; Darro, F. Synthesis and in vitro antitumor activity of an isomer of the marine pyridoacridine alkaloid ascididemin and related compounds. Bioorg. Med. Chem. 2003, 11, 4351-4356.
7. Feliu, L.; Vera-Luque, P.; Albericio, F.; Alvarez, M. Advances in solid-phase cycloadditions for heterocyclic synthesis. J. Comb. Chem. 2007, 9, 521-565.
8. LaBarbera, D.V.; Bugni, T.S.; Ireland, C.M. The total synthesis of neoamphimedine. J. Org. Chem. 2007, 72, 8501-8505.
9. Marshall, K.M.; Barrows, L.R. Biological activities of pyridoacridines. Nat Prod. Rep. 2004, 21, 731-751.
10. Marshall, K.M.; Matsumoto, S.S.; Holden, J.A.; Concepcion, G.P.; Tasdemir, D.; Ireland, C.M.; Barrows, L.R. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine. Biochem. Pharmacol. 2003, 66, 447-458.
11. Tasdemir, D.; Marshall, K.M.; Mangalindan, G.C.; Concepcion, G.P.; Barrows, L.R.; Harper, M.K.; Ireland, C.M. Deoxyamphimedine, a new pyridoacridine alkaloid from two tropical Xestospongia sponges. J. Org. Chem. 2001, 66, 3246-3248.
12. Fridovich, I. Biological effects of the superoxide radical. Arch. Biochem. Biophys. 1986, 247, 1-11.
13. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine. 2nd ed.; Clarendon Press: Oxford, USA, 1989.
14. Spencer, J. P.; Jenner, A.; Aruoma, O. I.; Cross, C. E.; Wu, R.; Halliwell, B. Oxidative DNA damage in human respiratory tract epithelial cells. Time course in relation to DNA strand breakage. Biochem. Biophys. Res. Commun. 1996, 224, 17-22.
15. Sarker, A.H.; Watanabe, S.; Seki, S.; Akiyama, T.; Okada, S. Oxygen radical-induced single-strand DNA breaks and repair of the damage in a cell-free system. Mutat. Res. 1995, 337, 85-95.
16. Ferri, E.; Gattavecchia, E.; Feroci, G.; Battino, M. Interaction between reactive oxygen species and coenzyme Q10 in an aprotic medium: a cyclic voltammetry study. Mol. Aspects Med. 1994, 15 Suppl, s83-s88.
17. Crawford, P.W.; Gross, J.; Lawson, K.; Cheng, C.C.; Dong, Q.; Liu, D.F.; Luo, Y.L.; Szczepankiewicz, B.G.; Heathcock, C.H. Electrochemical properties of some biologically active quinone derivatives: furanquinones, pyridoquinones, and diplamine, a cytotoxic pyridoacridine alkaloid. J. Electrochem. Soc. 1997, 144, 3710-3715.
18. Malins, D.C.; Holmes, E.H.; Polissar, N.L.; Gunselman, S.J. The etiology of breast cancer. Characteristic alteration in hydroxyl radical-induced DNA base lesions during oncogenesis with potential for evaluating incidence risk. Cancer 1993, 71, 3036-3043.
19. Cortes, F.; Pinero, J.; Palitti, F. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8. Mutat. Res. 1993, 288, 281-289.
20. Cantoni, O.; Murray, D.; Meyn, R.E. Induction and repair of DNA single-strand breaks in EM9 mutant CHO cells treated with hydrogen peroxide. Chem. Biol. Interact. 1987, 63, 29-38.
21. Messer, J.; Reynolds, M.; Stoddard, L.; Zhitkovich, A. Causes of DNA single-strand breaks during reduction of chromate by glutathione in vitro and in cells. Free Radic. Biol. Med. 2006, 40, 1981-1992.
22. Jeggo, P.A.; Caldecott, K.; Pidsley, S.; Banks, G.R. Sensitivity of Chinese hamster ovary mutants defective in DNA double strand break repair to topoisomerase II inhibitors. Cancer Res. 1989, 49, 7057-7063. (Pubitemid 20016593)
23. Ding, Q.; Chichak, K.; Lown, J.W. Pyrroloquinoline and pyridoacridine alkaloids from marine sources. Curr. Med. Chem. 1999, 6, 1-27.
24. Matsumoto, S.S.; Biggs, J.; Copp, B.R.; Holden, J.A.; Barrows, L.R. Mechanism of ascididemininduced cytotoxicity. Chem. Res. Toxicol. 2003, 16, 113-122.
25. McDonald, L.A.; Eldredge, G.S.; Barrows, L.R.; Ireland, C.M. Inhibition of topoisomerase II catalytic activity by pyridoacridine alkaloids from a Cystodytes sp. ascidian: a mechanism for the apparent intercalator-induced inhibition of topoisomerase II. J. Med. Chem. 1994, 37, 3819-3827.
26. Matsumoto, S.S.; Sidford, M.H.; Holden, J.A.; Barrows, L.R.; Copp, B.R. Mechanism of action studies of cytotoxic marine alkaloids: ascididemin exhibits thiol-dependent oxidative DNA cleavage. Tetrahedron Lett. 2000, 41, 1667-1670. (Pubitemid 30131126)
27. Herman, E.H.; Ferrans, V.J. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (+/-)-1,2-bis(3,5-dioxopiperazinyl- 1-yl)propane (ICRF-187). Cancer Res. 1981, 41, 3436-3440. (Pubitemid 11063616)
28. Malins, D.C. Identification of hydroxyl radical-induced lesions in DNA base structure: biomarkers with a putative link to cancer development. J. Toxicol. Environ. Health 1993, 40, 247-261.
29. Doroshow, J.H. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc. Natl. Acad. Sci. USA 1986, 83, 4514-4518.
30. Doroshow, J.H.; Davies, K.J. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 1986, 261, 3068-3074.
31. Doroshow, J.H.; Locker, G.Y.; Ifrim, I.; Myers, C.E. Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J. Clin. Invest. 1981, 68, 1053-1064.
32. Doroshow, J.H.; Locker, G.Y.; Myers, C.E. Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin. J. Clin. Invest. 1980, 65, 128-135.
33. Herman, E.H.; Ferrans, V.J.; Jordan, W.; Ardalan, B. Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. Res. Commun. Chem. Pathol. Pharmacol. 1981, 31, 85-97.
34. de Guzman, F.S.; Carte, B.; Troupe, N.; Faulkner, D.J.; Harper, M.K.; Concepcion, G.P.; Mangalindan, G.C.; Matsumoto, S.S.; Barrows, L.R.; Ireland, C.M. Neoamphimedine: a new pyridoacridine topoisomerase II inhibitor which catenates DNA. J. Org. Chem. 1999, 64, 1400-1402.
35. Englund, P.T. The replication of kinetoplast DNA networks in Crithidia fasciculata. Cell 1978, 14, 157-168. (Pubitemid 8340443)
36. Matsumoto, S.S.; Haughey, H.M.; Schmehl, D.M.; Venables, D.A.; Ireland, C.M.; Holden, J.A.; Barrows, L.R. Makaluvamines vary in ability to induce dose-dependent DNA cleavage via topoisomerase II interaction. Anticancer Drugs 1999, 10, 39-45. (Pubitemid 29150179)
37. Holden, J.A.; Rolfson, D.H.; Low, R.L. DNA topoisomerase I from human placenta. Biochim. Biophys. Acta 1990, 1049, 303-310.
38. Mossman, T. Rapid colorimetric assay for cell growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63. (Pubitemid 14203433)
39. Kokoshka, J.M.; Capson, T.L.; Holden, J.A.; Ireland, C.M.; Barrows, L.R. Differences in the topoisomerase I cleavage complexes formed by camptothecin and wakayin, a DNA-intercalating marine natural product. Anticancer Drugs 1996, 7, 758-765. (Pubitemid 26388766)
40. Bonnard, I.; Bontemps, N.; Lahmy, S.; Banaigs, B.; Combaut, G.; Francisco, C.; Colson, P.; Houssier, C.; Waring, M.J.; Bailly, C. Binding to DNA and cytotoxic evaluation of ascididemin, the major alkaloid from the Mediterranean ascidian Cystodytes dellechiajei. Anticancer Drug Des. 1995, 10, 333-346.
41. Radisky, D.C.; Radisky, E. .; Barrows, L.R.; Copp, B.R.; Kramer, R.A.; Ireland, C.M. Novel cytotoxic topoisomerase II inhibiting pyrroloiminoquinones from Fijian sponges of the Genus Zyzzya. J. Am. Chem. Soc. 1993, 115, 1632-1638.